OpportunityTitle: Achieving and Sustaining TB/HIV Collaborative Activities in Cambodia under the President&apos;s Emergency Plan for AIDS Relief (PEPFAR)
AdditionalInformationOnEligibility: The National Tuberculosis and Leprosy  Program (CENAT), housed in Cambodia&apos;s Ministry of Health, is legally responsible for managing and overseeing tuberculosis prevention and treatment throughout the Kingdom of Cambodia. CENAT has been the lead for HIV/AIDS care and treatment for patients with TB co-infection since it was established. It is the sole official government source in Cambodia for providing these public health services. There is no other entity within the Kingdom of Cambodia with the sole legal mandate from the Royal Government of Cambodia to manage tuberculosis prevention and treatment, including developing health policy guidelines and overseeing the provision of comprehensive health services for tuberculosis control.    CENAT possesses not only the mandate but also the leadership capacity to manage these funds efficiently and in accordance with PEPFAR guidance and USG regulations.     Therefore, as part of Cambodia&apos;s effort to build capacity and sustainability and later resultant indigenous capacity in local organizations by providing HIV/AIDS  care and treatment for patients with TB co-infection, it is imperative funding be available to the National Tuberculosis and Leprosy  Program (CENAT) housed in Cambodia&apos;s Ministry of Health.
Description: CDC Cambodia has partnered directly with the National Center for Tuberculosis and Leprosy Control (CENAT) since 2009 through a cooperative agreement to diagnose tuberculosis (TB) in HIV-positive patients and detect multi-drug resistant TB. In this follow-on funding opportunity, the national tuberculosis control program will scale-up, monitor, and supervise national TB/HIV activities, in coordination with the National Center for HIV/AIDS, Dermatology, and STDs (NCHADS). The objectives are to achieve and sustain nationwide scale up of the &#147;Three Is&#148; (intensified case finding [ICF], isoniazid preventive therapy, and infection control) and rapid, early treatment of co-infected patients with both antiretroviral and anti-tuberculosis regimens. To promote long-term sustainability, the cooperative agreement will foster monitoring and evaluation systems and strengthen the capacity of national health care staff to correctly diagnose and treat TB using evidence-based, cost-effective TB diagnostic algorithms.
GrantorContactEmailDescription: PGO TIM
GrantorContactText: CDC Procurement and Grants Office  &lt;br/&gt;Technical Information Management Section &lt;br/&gt;E-mail: pgotim@cdc.gov &lt;br/&gt;Phone: 770-488-2700 &lt;br/&gt;